[144] Surgery Partners, Inc. SEC Filing

Rhea-AI Filing Summary

Surgery Partners, Inc. (SGRY) Form 144 shows a proposed sale of 5,627 common shares through UBS Financial Services on September 26, 2025. The shares were recorded as acquired the same day via equity compensation and an equity option exercise. The reported aggregate market value for the proposed sale is $123,794 and the issuer has 128,209,410 shares outstanding. The filing also lists multiple recent open-market sales by Wayne DeVeydt totaling 713,977 shares sold across dates from August 21, 2025 through September 23, 2025 with individual gross proceeds reported for each lot.

Positive

• Form 144 was filed and contains required details including broker, share counts, acquisition method, and aggregate market value
• Proposed sale size is small relative to outstanding shares (5,627 vs 128,209,410 outstanding)

Negative

• Significant insider selling disclosed: Wayne DeVeydt sold 713,977 shares across multiple dates in the past three months
• Immediate exercise-and-sale: the 5,627 shares were acquired and marked for sale on the same date (09/26/2025), indicating an immediate disposition

Insights

Securities Analyst

TL;DR: Insider exercised options and filed a timely Form 144 to sell 5,627 shares; sizable prior sales by a second insider were disclosed.

The Form 144 documents a proposed brokered sale of 5,627 common shares acquired by equity compensation and an option exercise on the same date, indicating a near-term disposition. The filing includes explicit market value ($123,794) and the company share count (128,209,410), allowing calculation of the sale's relative size (very small fraction of outstanding shares). Separately, the filing lists detailed historic sales by Wayne DeVeydt totaling 713,977 shares with individual gross proceeds for each transaction. From a trading-disclosure perspective the filing is complete and allows investors to verify timing and proceeds; it does not include any forward-looking or operational data.

Corporate Governance Expert

TL;DR: Multiple reported insider dispositions may be material to shareholders' perception but the Form 144 itself is a routine required disclosure.

The document shows an insider exercise-and-sale of 5,627 shares and extensive recent sales by another person, Wayne DeVeydt, amounting to 713,977 shares. These entries are factual disclosures required under Rule 144 and the filer certifies no undisclosed material adverse information. The filing provides identity of broker, transaction dates, and gross proceeds for past sales, which supports transparency on insider liquidity events. The filing does not provide reasons for the sales or link them to company performance.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
common	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	5627	123794	128209410	09/26/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
common	09/26/2025	equity compensation	Surgery Partners, Inc.			5627	09/26/2025	equity option exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	08/21/2025	100000	2299011
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	08/26/2025	25000	572717
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	08/27/2025	11865	271756
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/02/2025	25000	562150
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/03/2025	25000	560251
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/04/2025	25000	562756
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/05/2025	25000	563682
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/08/2025	2014	45207
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/11/2025	100000	2200741
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/12/2025	28700	628929
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/16/2025	25000	541518
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/17/2025	85785	1873875
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/18/2025	150000	3294425
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/19/2025	10613	234547
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/22/2025	50000	1092666
Wayne DeVeydt 9910 Cumberland Drive Fishers IN 46037	common	09/23/2025	25000	550386

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for SGRY disclose?

It discloses a proposed brokered sale of 5,627 common shares on 09/26/2025, acquired that same day by equity compensation and an option exercise, with aggregate market value $123,794.

Who is the broker named in the SGRY Form 144?

UBS Financial Services Inc., 1000 Harbor Blvd, 3rd Floor, Weehawken, NJ is listed as the broker for the proposed sale.

How many shares has Wayne DeVeydt sold recently according to the filing?

Wayne DeVeydt sold 713,977 shares in multiple transactions between August 21, 2025 and September 23, 2025, with gross proceeds reported for each sale.

What is the issuer's share count reported in the Form 144?

The filing reports 128,209,410 shares outstanding for the issuer.

Does the Form 144 state any undisclosed material information about Surgery Partners?

The filer represents they do not know any material adverse information not publicly disclosed; the document contains no operational or forward-looking company details.